Company Filing History:
Years Active: 2008
Title: Kevin E Noonan: Innovator in Microfluidics Technology
Introduction
Kevin E Noonan stands out as a noteworthy inventor based in Chicago, IL, whose contributions have significant implications in the field of microfluidics. With a focus on efficient analysis and synthesis at micro scales, his innovative approach merges technology with biological processes.
Latest Patents
Kevin E Noonan holds one patent titled "Centripetally-Motivated Microfluidics System for Performing In Vitro Hybridization and Amplification of Nucleic Acids". This invention encompasses methods and apparatuses designed for conducting microanalytic and microsynthetic analyses. The central idea of the patent revolves around a microsystem platform and a micromanipulation device that harnesses centripetal force from platform rotation to facilitate fluid movement through microchannels. The invention boasts arrays of thermal control regions, allowing applied fluids to be maintained at specific temperatures, which are influenced by various factors such as channel length, cross-sectional dimensions, and rotational speed.
Career Highlights
Kevin is associated with Tecan Trading AG, a company committed to providing innovative laboratory instruments and solutions. His work contributes to the evolution of microfluidics, bridging gaps between technology and complex biological analysis.
Collaborations
Throughout his career, Kevin has collaborated with accomplished professionals such as Gregory John Kellogg and Bruce L Carvalho. These partnerships have likely fostered a creative environment conducive to groundbreaking inventions and the advancement of microfluidic applications.
Conclusion
Kevin E Noonan exemplifies the spirit of innovation in microfluidics, with a distinct focus on systems that enhance analytical precision. His noteworthy patent not only highlights his inventive capabilities but also sets a foundation for future advancements in biological applications. As he continues to work with Tecan Trading AG and collaborate with esteemed colleagues, the potential for further contributions to the field remains promising.